CSI Market
Sign In | Register

Tarsus Pharmaceuticals Inc (TARS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TARS Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Tarsus Pharmaceuticals Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent204.60
Marketable Securities, Current SH245.10
Cash & Short-term Investments449.00
Accounts receivable96.03
Other Receivables, Net, Current2.28
Inventories4.38
Other Current Assets0.00
Prepaid Expense, Current AS9.61
Total Current Assets561.99
Equipment/Property/Plant Net22.34
Intangible Assets6.89
Long-term investments6.68
Deferred, Prepaid and Other Assets, Noncurrent1.29
Other Assets, Noncurrent11.96
Restricted Cash Current-
Cash And Cash Equivalents Fair Value Disclosure102.19
Operating Lease Right Of Use Asset9.99
Total Assets611.14
Liabilities
Accounts Payable, Current AC40.14
Employee-related Liabilities, Current AC11.89
Other Liabilities, Current121.62
Taxes Payable2.11
Total Current Liabilities175.75
Long-term debt72.76
Total Long-term Debt72.76
Financial Instruments, Insurance, Noncurrent0.00
Other liabilities, Noncurrent15.90
Total Liabilities264.41
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock799.43
Retained Earnings / Accumulated Deficit-452.15
Accumulated Other Comprehensive Income-0.56
Other Equity-0.56
Common Stockholder's Equity346.73
Total Stockholder's Equity346.73
Liabilities & Stockholder's Equity611.14
4 historic quarters locked

Sign in to unlock the full Tarsus Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Tarsus Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001819790-26-000064

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.